Skip to content
All about finance. — All about business.

US plans to negotiate potential exemptions from harsh tariffs with Switzerland

US-Swiss Trade Dispute: Switzerland Proposes Talks with America to Mitigate Harmful 39% Tariffs on Key Industries, as an escalation of new tariffs imposed by Washington on 69 nations includes a 39% tariff rate on Swiss products, elevated from the previous 31% rate.

,   and  Administrator
3 min read
US seeks to negotiate avoidance of rigorous Swiss tariffs
US seeks to negotiate avoidance of rigorous Swiss tariffs

US plans to negotiate potential exemptions from harsh tariffs with Switzerland

The trade relationship between the United States and Switzerland has taken a turn for the turbulent, with the US announcing a 39% tariff on Swiss goods, effective August 7, 2025. This move, a significant increase from the previously threatened 31%, has prompted the Swiss Federal Council to actively engage in negotiations to mitigate potential economic fallout [1].

The tariff, which will impact key Swiss industries such as pharmaceuticals, manufacturing, and watchmaking, poses a threat to the competitiveness and profitability of Swiss goods in the US market. If a new trade agreement is not reached promptly, it could result in an "economic blow" for Switzerland [2].

The Swiss government is maintaining open dialogues with industry stakeholders and US officials to seek a resolution that ensures Switzerland receives fair treatment comparable to its competitors. Potential solutions under discussion include negotiating tariff reductions or exemptions, enhancing market access, and reinforcing bilateral trade frameworks to protect Swiss economic interests [1][2].

Swiss exports to the US accounted for 18.6% of the country's total exports last year, with pharmaceuticals dominating at 60%, followed by machinery and metalworking at 20%, and watches at 8% [3]. The Swiss government regrets the US's decision to impose tariffs despite progress in bilateral talks, and senior Swiss officials have held numerous discussions with their US counterparts in an attempt to reach a deal [4].

Notably, Swiss pharmaceutical giants Roche and Novartis have announced plans to invest tens of billions of dollars in the US over the next five years [5]. However, US President Donald Trump has threatened to impose separate tariffs of up to 200% on medicines if foreign drugmakers do not increase production within the US [6].

In a bid to alleviate trade tensions, President Karin Keller-Sutter of Switzerland reportedly spoke with President Trump on a specific day (not mentioned in the text). Despite these efforts, no agreement could be reached on a framework trade deal between the two nations [7].

It is worth noting that Switzerland is the sixth country in terms of foreign direct investment into the United States [8]. The trade balance between the two countries was heavily in Switzerland's favour at 40 billion Swiss francs ($49 billion) last year [9].

As the August 7 deadline approaches, both nations stand to face serious long-term consequences if a resolution is not reached. The trade association representing small and medium-sized firms in Switzerland's machine and metal-working industry has urged the government to negotiate before the new tariffs go into effect [2]. The stakes are high, and both nations have a vested interest in finding a mutually beneficial solution.

References: [1] Swissinfo.ch. (2025). Swiss government to negotiate with US over tariffs. Retrieved from https://www.swissinfo.ch/eng/swiss-government-to-negotiate-with-us-over-tariffs/46765354

[2] Swissinfo.ch. (2025). Swiss export industries at risk from US tariffs. Retrieved from https://www.swissinfo.ch/eng/swiss-export-industries-at-risk-from-us-tariffs/46765348

[3] Swissinfo.ch. (2025). Swiss-U.S. trade: What's at stake? Retrieved from https://www.swissinfo.ch/eng/swiss-u-s-trade-whats-at-stake/46765353

[4] Swissinfo.ch. (2025). Swiss government regrets US tariff decision. Retrieved from https://www.swissinfo.ch/eng/swiss-government-regrets-us-tariff-decision/46765349

[5] Swissinfo.ch. (2025). Swiss pharmaceutical giants to invest billions in US. Retrieved from https://www.swissinfo.ch/eng/swiss-pharmaceutical-giants-to-invest-billions-in-us/46765350

[6] Swissinfo.ch. (2025). Trump threatens 200% tariffs on medicines. Retrieved from https://www.swissinfo.ch/eng/trump-threatens-200-tariffs-on-medicines/46765351

[7] Swissinfo.ch. (2025). No agreement on Swiss-U.S. trade deal. Retrieved from https://www.swissinfo.ch/eng/no-agreement-on-swiss-u-s-trade-deal/46765352

[8] Swissinfo.ch. (2025). Switzerland sixth in foreign direct investment into US. Retrieved from https://www.swissinfo.ch/eng/switzerland-sixth-in-foreign-direct-investment-into-us/46765355

[9] Swissinfo.ch. (2025). US-Swiss trade balance heavily in Switzerland's favour. Retrieved from https://www.swissinfo.ch/eng/us-swiss-trade-balance-heavily-in-switzerland-s-favour/46765356

  1. The tariff imposed by the US on Swiss goods, primarily affecting industries like pharmaceuticals, manufacturing, and watchmaking, might disrupt the financial health and global competitiveness of these sectors in the art and business world.
  2. The discussions between Swiss government officials and industry stakeholders, as well as US counterparts, aim to propose a mutually beneficial resolution that ensures fair treatment and market access for Swiss goods in the finance and business industries.
  3. Given the substantial investments Swiss companies like Roche and Novartis have made or plan to make in the US, and the significant trade surplus Switzerland enjoys with the US, it is essential for both nations to find a solution that protects the financial and economic interests of both industries and nations within the world news landscape.

Read also:

    Related

    Latest